{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:04:34Z","timestamp":1792789474483,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.virusres.2024.199442","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T04:20:14Z","timestamp":1722399614000},"page":"199442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage"],"prefix":"10.1016","volume":"348","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-6483","authenticated-orcid":false,"given":"Jagdev","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Iredell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiran","family":"Selvadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/v13010051","article-title":"Bacteriophage treatment: critical evaluation of its application on world health organization priority pathogens","volume":"13","author":"Al-Ishaq","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2024.199442_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105461","article-title":"Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: a systematic review and meta-analysis","volume":"165","author":"Bonyadi","year":"2022","journal-title":"Microb. Pathogen."},{"issue":"2","key":"10.1016\/j.virusres.2024.199442_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0004","doi-asserted-by":"crossref","first-page":"e28281","DOI":"10.4161\/bact.28281","article-title":"Molecular architecture of tailed double-stranded DNA phages","volume":"4","author":"Fokine","year":"2014","journal-title":"Bacteriophage"},{"issue":"Supplement_5","key":"10.1016\/j.virusres.2024.199442_bib0005","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1093\/cid\/ciad483","article-title":"Therapeutic phages as modulators of the immune response: practical implications","volume":"77","author":"G\u00f3rski","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2024.199442_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/v10060288","article-title":"Phage therapy: what have we learned?","volume":"10","author":"G\u00f3rski","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2024.199442_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231225874","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with Phe508del mutation: evidence from randomized controlled trials","volume":"12","author":"He","year":"2024","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.virusres.2024.199442_bib0008","doi-asserted-by":"crossref","unstructured":"Hisert K.B., Birket S.E., Clancy J.P., et al. Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy. Lancet 2023;11(10):916\u2013931.","DOI":"10.1016\/S2213-2600(23)00324-7"},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcf.2020.10.008","article-title":"Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis","volume":"20","author":"Jackson","year":"2021","journal-title":"J. Cystic Fibrosis"},{"key":"10.1016\/j.virusres.2024.199442_bib0010","unstructured":"LyseNTech. Bacteriophage bank listing. 2009; http:\/\/www.phagebank.or.kr\/phage\/eng_bp_list.jsp."},{"issue":"3","key":"10.1016\/j.virusres.2024.199442_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00138-18","article-title":"Cystic Fibrosis and pseudomonas aeruginosa: the host-microbe interface","volume":"32","author":"Malhotra","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"issue":"19","key":"10.1016\/j.virusres.2024.199442_bib0012","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ppul.24535","article-title":"Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections","volume":"55","author":"Milczewska","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"10","key":"10.1016\/j.virusres.2024.199442_bib0014","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist","volume":"133","author":"Nichols","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virusres.2024.199442_bib0015","first-page":"1165","article-title":"Regulatory aspects of the therapeutic use of bacteriophages","author":"Pelfrene","year":"2021","journal-title":"Europe"},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0016","doi-asserted-by":"crossref","first-page":"fuab040","DOI":"10.1093\/femsre\/fuab040","article-title":"Recent progress toward the implementation of phage therapy in Western medicine","volume":"46","author":"Pirnay","year":"2022","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.virusres.2024.199442_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0019","article-title":"Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and <em>Pseudomonas aeruginosa<\/em>","volume":"10","author":"Singh","year":"2023","journal-title":"BMJ Open Respir. Res."},{"issue":"10408","key":"10.1016\/j.virusres.2024.199442_bib0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.virusres.2024.199442_bib0021","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages","volume":"7","author":"Van Belleghem","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T05:09:05Z","timestamp":1728536945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170224001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"alternative-id":["S0168170224001357"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199442","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199442"}}